Last update: July 31, 2018
Moderately safe. Probably compatible.
Mild risk possible. Follow up recommended.
Read the Comment.
A prokinetic from the benzamide group, a dopamine antagonist and similar to metoclopramide (Humax 2008).
Used IV, IM and orally every 8 to 12 hours for the treatment of nausea and vomiting.
Since the last update we have not found published data on its excretion in breastmilk.
Due to its chemical similarity to metoclopramide, its excretion in breastmilk could be minimal.
Due to its inhibitory effect on dopamine (DrugBank.com), milk production could increase due to an increase in prolactin (Minapharm 2014, Humax 2008).
A product with very few bibliographical references and sold in very few countries.
Until there is more published data on this drug in relation to breastfeeding, safer known alternatives may be preferable.
Suggestions made at e-lactancia are done by APILAM´s pediatricians and pharmacists, and are based on updated scientific publications.
It is not intended to replace the relationship you have with your doctor but to compound it.
Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.
Thank you for helping to protect and promote breastfeeding.
e-lactancia is a resource recommended by Academy of Breastfeeding Medicine from United States of America
Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM